☰

Franklin Schneier - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Neuroscience
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhu X, Lazarov A, Dolan S, Bar-Haim Y, Dillon DG, Pizzagalli DA, Schneier F. Resting state connectivity predictors of symptom change during gaze-contingent music reward therapy of social anxiety disorder. Psychological Medicine. 1-9. PMID 35314008 DOI: 10.1017/S0033291721005171  0.363
2021 Umemoto A, Cole SL, Allison GO, Dolan S, Lazarov A, Auerbach RP, Schneier F. Neurophysiological predictors of gaze-contingent music reward therapy among adults with social anxiety disorder. Journal of Psychiatric Research. 143: 155-162. PMID 34487992 DOI: 10.1016/j.jpsychires.2021.09.022  0.324
2020 Fyer AJ, Schneier FR, Simpson HB, Choo TH, Tacopina S, Kimeldorf MB, Steinglass JE, Wall M, Walsh BT. Heterogeneity in Fear Processing across and within Anxiety, Eating, and Compulsive Disorders. Journal of Affective Disorders. 275: 329-338. PMID 32734926 DOI: 10.1016/J.Jad.2020.03.091  0.329
2019 Suarez-Jimenez B, Zhu X, Lazarov A, Mann JJ, Schneier F, Gerber A, Barber JP, Chambless DL, Neria Y, Milrod B, Markowitz JC. Anterior hippocampal volume predicts affect-focused psychotherapy outcome. Psychological Medicine. 1-7. PMID 30773148 DOI: 10.1017/S0033291719000187  0.3
2018 Zhu X, Suarez-Jimenez B, Lazarov A, Helpman L, Papini S, Lowell A, Durosky A, Lindquist MA, Markowitz JC, Schneier F, Wager TD, Neria Y. Exposure-based therapy changes amygdala and hippocampus resting-state functional connectivity in patients with posttraumatic stress disorder. Depression and Anxiety. PMID 30260530 DOI: 10.1002/Da.22816  0.334
2018 Reinen J, Whitton A, Pizzagalli D, Silfstein M, Abi-Dargham A, McGrath P, Iosifescu DV, Schneier F. 252. Major Depressive Disorder is Associated With Blunted Learning Signals in Medial Prefrontal Cortex and Putamen When Seeking Monetary Reward Biological Psychiatry. 83: S101-S102. DOI: 10.1016/J.Biopsych.2018.02.271  0.323
2018 Schneier F, Slifstein M, Whitton A, Pizzagalli D, Reinen J, McGrath P, Iosifescu D, Abi-Dargham A. 251. Dopamine Release in Treatment-Naïve Major Depressive Disorder: A [11C]-(+)-PHNO Positron Emission Tomography Study Biological Psychiatry. 83: S101. DOI: 10.1016/J.Biopsych.2018.02.270  0.327
2017 Cohen JN, Drabick DAG, Blanco C, Schneier FR, Liebowitz MR, Heimberg RG. Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance. Journal of Anxiety Disorders. 52: 79-87. PMID 29102818 DOI: 10.1016/J.Janxdis.2017.10.004  0.334
2017 Schneier FR, Moskow DM, Choo TH, Galfalvy H, Campeas R, Sanchez-Lacay A. A randomized controlled pilot trial of vilazodone for adult separation anxiety disorder. Depression and Anxiety. PMID 29071764 DOI: 10.1002/Da.22693  0.321
2017 Rodebaugh TL, Levinson CA, Langer JK, Weeks JW, Heimberg RG, Brown PJ, Menatti AR, Schneier FR, Blanco C, Liebowitz MR. The structure of vulnerabilities for social anxiety disorder. Psychiatry Research. 250: 297-301. PMID 28199950 DOI: 10.1016/J.Psychres.2017.01.073  0.322
2017 Zhu X, Suarez-Jimenez B, Helpman L, Markowitz J, Papini S, Durosky A, Hilburn A, Schneier F, Lindquist M, Wager T, Neria Y. 237. PTSD Exposure-Based Treatment Changes Amygdala and Hippocampus Resting State Functional Connectivity in PTSD Biological Psychiatry. 81: S97-S98. DOI: 10.1016/J.Biopsych.2017.02.251  0.308
2016 Zhu X, Helpman L, Papini S, Schneier F, Markowitz JC, Van Meter PE, Lindquist MA, Wager TD, Neria Y. Altered resting state functional connectivity of fear and reward circuitry in comorbid PTSD and major depression. Depression and Anxiety. PMID 28030757 DOI: 10.1002/Da.22594  0.328
2016 Steinglass JE, Lempert KM, Choo TH, Kimeldorf MB, Wall M, Walsh BT, Fyer AJ, Schneier FR, Simpson HB. Temporal discounting across three psychiatric disorders: Anorexia nervosa, obsessive compulsive disorder, and social anxiety disorder. Depression and Anxiety. PMID 28009473 DOI: 10.1002/Da.22586  0.319
2016 Helpman L, Marin MF, Papini S, Zhu X, Sullivan GM, Schneier F, Neria M, Shvil E, Malaga Aragon MJ, Markowitz JC, Lindquist MA, Wager T, Milad M, Neria Y. Neural changes in extinction recall following prolonged exposure treatment for PTSD: A longitudinal fMRI study. Neuroimage. Clinical. 12: 715-723. PMID 27761402 DOI: 10.1016/J.Nicl.2016.10.007  0.379
2016 Lewis-Fernández R, Lam P, Lucak S, Galfalvy H, Jackson E, Fried J, Rosario M, de la Cruz AA, Sánchez-Lacay A, Díaz S, Schneier F. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder. Journal of Clinical Psychopharmacology. PMID 27755218 DOI: 10.1097/Jcp.0000000000000599  0.354
2016 Milrod B, Altemus M, Gross C, Busch F, Silver G, Christos P, Stieber J, Schneier F. Adult separation anxiety in treatment nonresponders with anxiety disorders: delineation of the syndrome and exploration of attachment-based psychotherapy and biomarkers. Comprehensive Psychiatry. 66: 139-45. PMID 26995247 DOI: 10.1016/j.comppsych.2016.01.004  0.343
2015 Rutherford BR, Bailey VS, Schneier FR, Pott E, Brown PJ, Roose SP. INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS. Depression and Anxiety. PMID 26437267 DOI: 10.1002/da.22433  0.319
2015 Schneier FR, Campeas R, Carcamo J, Glass A, Lewis-Fernandez R, Neria Y, Sanchez-Lacay A, Vermes D, Wall MM. COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL. Depression and Anxiety. 32: 570-9. PMID 26115513 DOI: 10.1002/Da.22384  0.31
2015 Cohen JN, Potter CM, Drabick DA, Blanco C, Schneier FR, Liebowitz MR, Heimberg RG. Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs. Psychiatry Research. 228: 65-71. PMID 25920804 DOI: 10.1016/J.Psychres.2015.04.014  0.34
2015 Talati A, Pantazatos SP, Hirsch J, Schneier F. A pilot study of gray matter volume changes associated with paroxetine treatment and response in social anxiety disorder. Psychiatry Research. 231: 279-85. PMID 25659476 DOI: 10.1016/J.Pscychresns.2015.01.008  0.363
2014 Potter CM, Wong J, Heimberg RG, Blanco C, Liu SM, Wang S, Schneier FR. Situational panic attacks in social anxiety disorder. Journal of Affective Disorders. 167: 1-7. PMID 25082106 DOI: 10.1016/J.Jad.2014.05.044  0.306
2014 Galbraith T, Heimberg RG, Wang S, Schneier FR, Blanco C. Comorbidity of social anxiety disorder and antisocial personality disorder in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Journal of Anxiety Disorders. 28: 57-66. PMID 24384071 DOI: 10.1016/J.Janxdis.2013.11.009  0.325
2014 Pantazatos SP, Talati A, Schneier FR, Hirsch J. Reduced anterior temporal and hippocampal functional connectivity during face processing discriminates individuals with social anxiety disorder from healthy controls and panic disorder, and increases following treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 425-34. PMID 24084831 DOI: 10.1038/Npp.2013.211  0.316
2014 Blanco C, Bragdon L, Schneier FR, Liebowitz MR. Psychopharmacology for Social Anxiety Disorder Social Anxiety: Clinical, Developmental, and Social Perspectives: Third Edition. 625-659. DOI: 10.1016/B978-0-12-394427-6.00022-4  0.303
2013 Lewis-Fernández R, Balán IC, Patel SR, Sánchez-Lacay JA, Alfonso C, Gorritz M, Blanco C, Schmidt A, Jiang H, Schneier F, Moyers TB. Impact of motivational pharmacotherapy on treatment retention among depressed Latinos. Psychiatry. 76: 210-22. PMID 23965261 DOI: 10.1521/psyc.2013.76.3.210  0.376
2013 Talati A, Pantazatos SP, Schneier FR, Weissman MM, Hirsch J. Gray matter abnormalities in social anxiety disorder: primary, replication, and specificity studies. Biological Psychiatry. 73: 75-84. PMID 22748614 DOI: 10.1016/J.Biopsych.2012.05.022  0.308
2013 Blanco C, Bragdon LB, Schneier FR, Liebowitz MR. The evidence-based pharmacotherapy of social anxiety disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 235-49. PMID 22436306 DOI: 10.1017/S1461145712000119  0.342
2012 Sandberg L, Busch F, Schneier F, Gerber A, Caligor E, Milrod B. Panic-focused psychodynamic psychotherapy in a woman with panic disorder and generalized anxiety disorder. Harvard Review of Psychiatry. 20: 268-76. PMID 23030215 DOI: 10.3109/10673229.2012.726527  0.353
2012 Buckner JD, Heimberg RG, Schneier FR, Liu SM, Wang S, Blanco C. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence. 124: 128-34. PMID 22266089 DOI: 10.1016/J.Drugalcdep.2011.12.023  0.307
2012 Xu Y, Schneier F, Heimberg RG, Princisvalle K, Liebowitz MR, Wang S, Blanco C. Gender differences in social anxiety disorder: results from the national epidemiologic sample on alcohol and related conditions. Journal of Anxiety Disorders. 26: 12-9. PMID 21903358 DOI: 10.1016/J.Janxdis.2011.08.006  0.395
2012 Blanco C, Bragdon LB, Schneier FR, Liebowitz MR. Evidence-based pharmacotherapy of social anxiety disorder Essential Evidence-Based Psychopharmacology, Second Edition. 90-109. DOI: 10.1017/CBO9780511910395.007  0.312
2011 Schneier FR. Pharmacotherapy of social anxiety disorder. Expert Opinion On Pharmacotherapy. 12: 615-25. PMID 21241211 DOI: 10.1517/14656566.2011.534983  0.305
2011 Schneier FR, Rodebaugh TL, Blanco C, Lewin H, Liebowitz MR. Fear and avoidance of eye contact in social anxiety disorder. Comprehensive Psychiatry. 52: 81-7. PMID 21220069 DOI: 10.1016/J.Comppsych.2010.04.006  0.302
2010 Schneier FR, Belzer KD, Kishon R, Amsel L, Simpson HB. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study. The Journal of Nervous and Mental Disease. 198: 458-61. PMID 20531128 DOI: 10.1097/NMD.0b013e3181da4d77  0.355
2010 Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, Vermes D, Erwin BA, Schmidt AB, Juster HR, Campeas R, Liebowitz MR. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Archives of General Psychiatry. 67: 286-95. PMID 20194829 DOI: 10.1001/Archgenpsychiatry.2010.11  0.32
2010 Schneier F, Pontoski K, Heimberg RG. Treatment of social anxiety disorder Anxiety Disorders: Theory, Research, and Clinical Perspectives. 260-270. DOI: 10.1017/CBO9780511777578.025  0.347
2008 Liebowitz MR, Schneier F, Stein DJ, Davidson JRT. Easing the burden of social anxiety disorder Journal of Clinical Psychiatry. 69: 1485-1496. PMID 19193348  0.301
2008 Vesga-López O, Schneier FR, Wang S, Heimberg RG, Liu SM, Hasin DS, Blanco C. Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The Journal of Clinical Psychiatry. 69: 1606-16. PMID 19192444 DOI: 10.4088/Jcp.V69N1011  0.326
2008 Choy Y, Schneier FR, Heimberg RG, Oh KS, Liebowitz MR. Features of the offensive subtype of Taijin-Kyofu-Sho in US and Korean patients with DSM-IV social anxiety disorder. Depression and Anxiety. 25: 230-40. PMID 17340609 DOI: 10.1002/Da.20295  0.33
2007 Marshall RD, Lewis-Fernandez R, Blanco C, Simpson HB, Lin SH, Vermes D, Garcia W, Schneier F, Neria Y, Sanchez-Lacay A, Liebowitz MR. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depression and Anxiety. 24: 77-84. PMID 16892419 DOI: 10.1002/Da.20176  0.328
2007 Schneier F. Review of current treatments for social anxiety disorder Psychiatric Times. 24: 21-24.  0.318
2005 Liebowitz MR, Ninan PT, Schneier FR, Blanco C. Integrating neurobiology and psychopathology into evidence-based treatment of social anxiety disorder. Cns Spectrums. 10: suppl13 1-11; discus. PMID 16404800  0.348
2004 Hambrick JP, Turk CL, Heimberg RG, Schneier FR, Liebowitz MR. Psychometric properties of disability measures among patients with social anxiety disorder. Journal of Anxiety Disorders. 18: 825-39. PMID 15474855 DOI: 10.1016/J.Janxdis.2003.10.004  0.309
2004 Belzer K, Schneier FR. Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment. Journal of Psychiatric Practice. 10: 296-306. PMID 15361744 DOI: 10.1097/00131746-200409000-00003  0.351
2004 Bruder GE, Schneier FR, Stewart JW, McGrath PJ, Quitkin F. Left hemisphere dysfunction during verbal dichotic listening tests in patients who have social phobia with or without comorbid depressive disorder. The American Journal of Psychiatry. 161: 72-8. PMID 14702253 DOI: 10.1176/appi.ajp.161.1.72  0.304
2003 Blanco C, Raza MS, Schneier FR, Liebowitz MR. The evidence-based pharmacological treatment of social anxiety disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 6: 427-42. PMID 14609440 DOI: 10.1017/S1461145703003791  0.35
2003 Schneier FR. Social anxiety disorder. Bmj (Clinical Research Ed.). 327: 515-6. PMID 12958087 DOI: 10.1136/bmj.327.7414.515  0.301
2003 Schneier FR, Blanco C, Campeas R, Lewis-Fernandez R, Lin SH, Marshall R, Schmidt AB, Sanchez-Lacay JA, Simpson HB, Liebowitz MR. Citalopram treatment of social anxiety disorder with comorbid major depression. Depression and Anxiety. 17: 191-6. PMID 12820174 DOI: 10.1002/Da.10112  0.371
2003 Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychological Medicine. 33: 611-22. PMID 12785463 DOI: 10.1017/S0033291703007414  0.35
2003 Erwin BA, Heimberg RG, Schneier FR, Liebowitz MR. Anger experience and expression in social anxiety disorder: Pretreatment profile and predictors of attrition and response to cognitive-behavioral treatment Behavior Therapy. 34: 331-350. DOI: 10.1016/S0005-7894(03)80004-7  0.366
2002 Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum. The Psychiatric Clinics of North America. 25: 757-74. PMID 12462859 DOI: 10.1016/S0193-953X(02)00018-7  0.325
2002 Mennin DS, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. Journal of Anxiety Disorders. 16: 661-73. PMID 12405524 DOI: 10.1016/S0887-6185(02)00134-2  0.313
2002 Harb GC, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. The psychometric properties of the Interpersonal Sensitivity Measure in social anxiety disorder. Behaviour Research and Therapy. 40: 961-79. PMID 12186358 DOI: 10.1016/S0005-7967(01)00125-5  0.303
1998 Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, Campeas R, Liebowitz MR. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology. 18: 10-8. PMID 9472837 DOI: 10.1097/00004714-199802000-00003  0.312
1996 Schneier FR, Garfinkel R, Kennedy B, Campeas R, Fallon B, Marshall R, O'Donnell L, Hogan T, Liebowitz MR. Ondansetron in the treatment of panic disorder. Anxiety. 2: 199-202. PMID 9160623 DOI: 10.1002/(SICI)1522-7154(1996)2:4<199::AID-ANXI7>3.0.CO;2-J  0.314
1993 Schneier FR, Carrasco JL, Hollander E, Campeas R, Fallon B, Saoud JB, Feerick J, Liebowitz MR. Alpidem in the treatment of panic disorder. Journal of Clinical Psychopharmacology. 13: 150-3. PMID 8096527  0.314
1992 Carrasco JL, Hollander E, Schneier FR, Liebowitz MR. Treatment outcome of obsessive compulsive disorder with comorbid social phobia. The Journal of Clinical Psychiatry. 53: 387-91. PMID 1459968  0.307
1990 Liebowitz MR, Hollander E, Schneier F, Campeas R, Welkowitz L, Hatterer J, Fallon B. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. Supplementum. 360: 29-34. PMID 2248064 DOI: 10.1111/J.1600-0447.1990.Tb05321.X  0.336
1990 Liebowitz MR, Hollander E, Schneier F, Campeas R, Fallon B, Welkowitz L, Cloitre M, Davies S. Anxiety and depression: discrete diagnostic entities? Journal of Clinical Psychopharmacology. 10: 61S-66S. PMID 2198302 DOI: 10.1097/00004714-199006001-00012  0.397
Show low-probability matches.